CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 20 enrolled
Drug / intervention
Dexamethasone +1 moredrug
Likely dose
Dexamethasone 20 MGfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00817479
NCT00817479Phase 4Completed
CompareCT.gov

Tumor Gene Expression Before and After Intraoperative Dexamethasone in Women With Ovarian Cancer

University of Chicago·interventional·Posted Jan 6, 2009·Updated Jul 13, 2016

In Brief

A Phase 4 clinical trial evaluating Dexamethasone and Placebo for Ovarian Cancer. Completed, enrolled 20 participants across 1 site.

Detailed Summary

The study objective is to compare changes in expression of glucocorticoid-induced genes that may be involved in cell survival signaling in the tumors of ovarian cancer patients before and after an intraoperative dose of 20mg dexamethasone.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOvarian Cancer
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJan 6, 2009
Enrollment StartJan 1, 2003
Primary CompletionJan 1, 2013
TodayJul 2, 2026
Enrollment to primary: 10 yearsPosted 17.5 years ago

Interventions

Dexamethasonedrug

20 MG OF DEXAMETHASONE OR PLACEBO

Placebodrug

Placebo saline